Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease

BACKGROUND: Danqi pill (DQP) is one of the most widely prescribed formulas and has been shown to have remarkable protective effect on coronary heart disease (CHD). However, its regulatory effects on lipid metabolism disorders haven’t been comprehensively studied so far. We aimed to explore the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hong, Wang, Qiyan, Shi, Tianjiao, Huo, Kuiyuan, Li, Chun, Zhang, Qian, Wang, Guoli, Wang, Yuanyuan, Tang, Binghua, Wang, Wei, Wang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802898/
https://www.ncbi.nlm.nih.gov/pubmed/27000070
http://dx.doi.org/10.1186/s12906-016-1083-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802898/
https://www.ncbi.nlm.nih.gov/pubmed/27000070
http://dx.doi.org/10.1186/s12906-016-1083-3

Ejemplares similares